Recent Advances With Chemotherapy for NSCLC: The ECOG Experience
January 2nd 1998Management of disseminated non-small-cell lung cancer has changed over the past 10 years. Newer agents, such as vinorelbine (Navelbine) and paclitaxel (Taxol), have been shown to modestly improve survival in patients with